Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 13 February 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Demand for medical applications in the Americas and aircraft applications in Europe remained strong, causing net sales and operating income to exceed the forecast. Ordinary income and net income attributable to owners of the parent also benefited from foreign exchange gains arising from fluctuations in foreign exchange rates and other factors. On a non-consolidated basis, ordinary income and net income decreased due to the rebound from having recorded a special dividend from a consolidated subsidiary in the previous fiscal year.
For loans to the consolidated subsidiary Advanex de Mexico S.de R.L. de C.V., the Company recorded ¥211 million as an extraordinary loss, representing a provision for doubtful accounts corresponding to the amount of negative net worth. There is no impact on consolidated results.
| Item | Details |
|---|---|
| Net Sales | ¥29,000 million → ¥29,679 million（+2.3%） |
| Operating profit | ¥1,200 million → ¥1,322 million（+10.2%） |
| Ordinary income | ¥1,000 million → ¥1,343 million（+34.3%） |
| Profit attributable to owners of the parent | ¥650 million → ¥1,027 million（+58.0%） |
| Net income per share | 158.32 yen and sen → 250.4 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 13 February 2026 |
| Previous-period results | Consolidated Net Sales ¥28,532 million (net income per share: yen and sen) / Operating profit ¥1,109 million (net income per share: yen and sen) / Ordinary income ¥170 million (net income per share: yen and sen) / Profit attributable to owners of the parent ¥-628 million (net income per share: yen and sen) / Net income per share ¥-153.13 million (net income per share: yen and sen) / Individual Net Sales ¥10,245 million (net income per share: yen and sen) / Operating profit ¥220 million (net income per share: yen and sen) / Ordinary income ¥1,346 million (net income per share: yen and sen) / Net income for the current fiscal year ¥586 million (net income per share: yen and sen) / Net income per share ¥142.87 million (net income per share: yen and sen) |
| Reason for the revision | Demand for medical applications in the Americas and aircraft applications in Europe remained strong, causing net sales and operating income to exceed the forecast. Ordinary income and net income attributable to owners of the parent also benefited from foreign exchange gains arising from fluctuations in foreign exchange rates and other factors. On a non-consolidated basis, ordinary income and net income decreased due to the rebound from having recorded a special dividend from a consolidated subsidiary in the previous fiscal year. |
| Details and amount of extraordinary loss | For loans to the consolidated subsidiary Advanex de Mexico S.de R.L. de C.V., the Company recorded ¥211 million as an extraordinary loss, representing a provision for doubtful accounts corresponding to the amount of negative net worth. There is no impact on consolidated results. |
| Consolidated / non-consolidated | Consolidated / non-consolidated (standalone) |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.On a consolidated basis, demand for medical applications in the Americas and aircraft applications in Europe remained strong, causing net sales and operating income to exceed the forecast. In addition, ordinary income and net income attributable to owners of the parent benefited from foreign exchange gains arising from fluctuations in foreign exchange rates and other factors. On a non-consolidated basis, ordinary income and net income decreased due to the反動 of having recorded a special dividend from a consolidated subsidiary in the previous fiscal year.